Drug
Carbon Monoxide clinical trials
- studies test it
- 9
- open now
- 0
- in phase 3
- 1
- first study started
- 2004
How studies write it
Studies that test it under each name
Combined with it in one product
Studies by the year they started
9 studies that test it; most in 2011 (2)
| Year | Studies |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2015 | 1 |
| 2017 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 4
- Phase 2
- 5
- Phase 3
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 2 · Other 7
Gilead Sciences (1) · National Institutes of Health Clinical Center (CC) (1) · Cedars-Sinai Medical Center (1) · Brigham and Women's Hospital (1) · Groningen Research Institute for Asthma and COPD (1) · Queen's University (1) · University Hospital Tuebingen (1) · University of Illinois at Chicago (1)
Often tested with
Tested in the same studies.
Ritonavir (1) · Atazanavir (1) · Darunavir (1) · Cobicistat (1) · Cobalt (1) · Cobicistat mixture with darunavir (1) · Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (1) · Abacavir, lamivudine drug combination (1)
Studies
Open first, then newest update. How each study uses Carbon Monoxide is read from its arms, and is right about nine times in ten.
Testing it · 9
- Study to Evaluate the Safety and Efficacy of Switching From Regimens Consisting of Boosted Atazanavir or Darunavir Plus Either Emtricitabine/Tenofovir or Abacavir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed HIV-1 Infected AdultsCompletedPhase 3Gilead SciencesNCT02603107Written as ATV/co
- Carbon Monoxide to Prevent Lung InflammationCompletedPhase 1National Institutes of Health Clinical Center (CC)NCT00094406Written as Carbon Monoxide
- Effects of Carbon Monoxide Breathing on Blood Vessel FunctionCompletedPhase 1Cedars-Sinai Medical CenterNCT03067701Written as Carbon Monoxide
- Study of Inhaled Carbon Monoxide to Treat Idiopathic Pulmonary FibrosisCompletedPhase 2Brigham and Women's HospitalNCT01214187Written as inhaled carbon monoxide
- Carbon Monoxide Therapy for Severe Pulmonary Arterial HypertensionWithdrawnPhase 1/2University of Illinois at ChicagoNCT01523548Written as Carbon Monoxide
- Safety and Tolerability Study of Inhaled Carbon Monoxide in Kidney Transplant PatientsWithdrawnPhase 2MallinckrodtNCT00531856Written as Inhaled carbon monoxide
- Study of Inhaling Carbon Monoxide to Treat Patients With Intestinal Paralysis After Colon Surgery.TerminatedPhase 2Queen's UniversityNCT01050712Written as Inhaled Carbon Monoxide
- Development of a New Method for Steady-State Measurement of NO Lung Diffusing Capacity in Healthy SubjectsStatus unknownPhase 1University Hospital TuebingenNCT00315965Written as Nitric oxide, Carbon monoxide, Helium
- Modification of Chronic Inflammation by Inhaled Carbon Monoxide in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD)CompletedPhase 2Groningen Research Institute for Asthma and COPDNCT00122694Written as carbon monoxide
Codes
What other systems call Carbon Monoxide · ClinicalTrials.gg INT007147
- MeSH (NLM) D002248Carbon MonoxideConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 7U1EE4V452CARBON MONOXIDEConfirmed FDA, NLM, Wikidata
- RxNorm 2037Confirmed FDA, Wikidata
- Wikidata Q2025carbon monoxideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C76742Carbon MonoxideOne source FDA
- DrugBank DB11588One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D002248 | Carbon Monoxide | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 7U1EE4V452 | CARBON MONOXIDE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 2037 | — | Confirmed FDA, Wikidata |
| Wikidata | Q2025 | carbon monoxide | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C76742 | Carbon Monoxide | One source FDA |
| DrugBank | DB11588 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.